<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Infectious adverse events related to endoscopic retrograde cholangiopancreatography (ERCP)
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrea Tringali, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Guido Costamagna, MD, FACG
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John R Saltzman, MD, FACP, FACG, FASGE, AGAF
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Stephen B Calderwood, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 26, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Biliary drainage, usually by endoscopic retrograde cholangiopancreatography (ERCP), is essential in the management of patients with acute obstructive cholangitis. However, acute cholangitis is the most common infectious adverse event associated with ERCP. It is important to use preventive strategies to reduce the risk of cholangitis and other abdominal infections related to ERCP.
        </p>
        <p>
         This topic will discuss pathogenesis, prevention, and an overview of management for infections related to ERCP. Other aspects of ERCP including indications, patient preparation, and noninfectious adverse events are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/632.html" rel="external">
          "Overview of endoscopic retrograde cholangiopancreatography (ERCP) in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/629.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/636.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) bleeding"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/634.html" rel="external">
          "Post-ERCP perforation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The clinical features, diagnosis, and management of acute cholangitis and acute cholecystitis are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/658.html" rel="external">
          "Acute cholangitis: Clinical manifestations, diagnosis, and management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/666.html" rel="external">
          "Acute calculous cholecystitis: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3684.html" rel="external">
          "Treatment of acute calculous cholecystitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          RATES OF BACTEREMIA AND INFECTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infections have been reported in up to 3 percent of patients undergoing ERCP [
         <a href="#rid1">
          1-6
         </a>
         ]. As an example, in a summary of 21 studies involving 16,855 adult patients, the rate of infection related to ERCP was 1.4 percent and the periprocedural mortality rate was 0.1 percent [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         Transient bacteremia that is not associated with sepsis may be common following ERCP. In patients with biliary obstruction, transient bacteremia rates of 18 percent have been reported, but the risk for subsequent sepsis is uncertain [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3916188022">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients undergoing ERCP, bacteremia may result from translocation of endogenous bacteria into the blood stream via mucosal trauma. In addition, injection of contrast during ERCP may also result in bacteria being introduced into a previously sterile space. Patients who have biliary obstruction and/or impaired host defenses are more susceptible to developing infection [
         <a href="#rid8">
          8,9
         </a>
         ]. The mechanism by which biliary obstruction can lead to sepsis is presumed to be elevated biliary pressure causing biliary-venous reflux [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2545.html" rel="external">
          "Antibiotic prophylaxis for gastrointestinal endoscopic procedures", section on 'Pathogenesis'
         </a>
         .)
        </p>
        <p>
         The most frequent organisms responsible for ERCP-related infections are enteric, gram-negative bacteria [
         <a href="#rid1">
          1,10,11
         </a>
         ]. Although polymicrobial enteric flora are often found in infected bile, single organisms are usually isolated from blood cultures in most patients with septic infection [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
         Gastrointestinal endoscopy-related transmission of infection occurs very rarely. However, duodenoscopes have been implicated in transmission of multidrug-resistant organisms such as carbapenem-resistant Enterobacteriaceae (CRE; including
         <em>
          Escherichia coli
         </em>
         ,
         <em>
          Klebsiella pneumoniae
         </em>
         ) [
         <a href="#rid12">
          12-14
         </a>
         ]. Strategies for endoscope reprocessing have been developed to reduce the risk of transmitting infection, and such protocols are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">
          "Preventing infection transmitted by gastrointestinal endoscopy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3128570497">
         <span class="h1">
          PREVENTIVE STRATEGIES
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients undergoing ERCP, the goal of a preventive strategy is to reduce the risk of post-ERCP infection, and these strategies include [
         <a href="#rid15">
          15
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antibiotic prophylaxis
         </strong>
         — Antibiotic prophylaxis is recommended in selected patients undergoing ERCP as outlined in the table  (
         <a class="graphic graphic_table graphicRef54121" href="/z/d/graphic/54121.html" rel="external">
          table 1
         </a>
         ). For example, antibiotic prophylaxis before ERCP is typically administered when incomplete biliary drainage is anticipated or when ERCP-guided cholangioscopy is planned. (See
         <a class="medical medical_review" href="/z/d/html/633.html" rel="external">
          "Cholangioscopy and pancreatoscopy", section on 'Patient preparation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Antibiotic prophylaxis and specific antibiotic regimens are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2545.html" rel="external">
          "Antibiotic prophylaxis for gastrointestinal endoscopic procedures", section on 'Endoscopic retrograde cholangiopancreatography (ERCP)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General endoscopic techniques
         </strong>
         – Endoscopic techniques for reducing the risk of infection include [
         <a href="#rid16">
          16
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Aspirating bile before injecting sterile contrast material to avoid using excessive hydrostatic pressure
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Using the minimum volume of contrast that is needed to obtain diagnostic fluoroscopic images (ie, biliary stones, biliary stricture)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Establishing biliary drainage
         </strong>
         – For patients with biliary obstruction, the goal of endoscopic intervention is to establish complete, long-term biliary drainage. When complete drainage is not possible, the approach is informed by the cause of obstruction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As an example, for patients with obstruction due to bile duct stones, a temporary plastic biliary stent is usually placed to establish drainage if the bile duct cannot be cleared during the initial endoscopic intervention. This is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/674.html" rel="external">
          "Endoscopic management of bile duct stones", section on 'Patients with incomplete duct clearance'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The approach to drainage for patients with malignant biliary obstruction is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">
          "Endoscopic stenting for malignant biliary obstruction", section on 'ERCP with biliary stent placement'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adhering to endoscope reprocessing protocols
         </strong>
         – Gastrointestinal endoscopes are devices that contact the mucous membranes, and such devices require high-level disinfection (HLD) to destroy microorganisms and prevent transmission of endoscopy-related infection. Protocols for endoscope disinfection and reprocessing are informed by regulatory agencies, manufacturers, and professional societies, and these issues are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">
          "Preventing infection transmitted by gastrointestinal endoscopy", section on 'Overview of endoscope reprocessing'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Disposable duodenoscopes may reduce the risk of endoscopy-related infection, especially for patients with risk factors (eg, those who are immunosuppressed). Studies suggest that the technical performance of disposable duodenoscopes is similar to reusable duodenoscopes [
         <a href="#rid17">
          17
         </a>
         ]; however, routine use of disposable equipment may be limited by cost. (See
         <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">
          "Preventing infection transmitted by gastrointestinal endoscopy", section on 'Duodenoscopes with disposable designs'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2679298129">
         <span class="h1">
          APPROACH TO THE PATIENT WITH SUSPECTED INFECTION
         </span>
        </p>
        <p class="headingAnchor" id="H2430157967">
         <span class="h2">
          When to suspect an ERCP-related infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         An infection should be suspected in patients who develop fever (temperature &gt;38⁰C; frequently with chills) and/or abdominal pain within 72 hours after ERCP.
        </p>
        <p class="headingAnchor" id="H1772363039">
         <span class="h2">
          Initial testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with a suspected ERCP-related infection based on symptoms and timing of presentation, the evaluation begins with the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laboratory testing – We obtain complete blood count, electrolytes, liver biochemical and function tests, amylase, and lipase. In patients with fever, blood cultures are obtained to guide antibiotic therapy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Imaging – The approach to initial diagnostic imaging is informed by patient presentation and clinician preference. For example, the authors of this topic typically obtain abdominal ultrasound to confirm the presence of pneumobilia (a sign that the sphincterotomy and/or biliary stent is patent) and to exclude acute cholecystitis, whereas other contributors begin the evaluation with cross-sectional imaging (eg, computed tomography scan or magnetic resonance imaging with cholangiopancreatography) [
         <a href="#rid18">
          18
         </a>
         ]. (See
         <a class="local">
          'Specific post-ERCP infections'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         The initial evaluation is also informed by clinical suspicion for other healthcare-associated infections (eg, pneumonia, catheter-related infection), and these conditions are discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/3813.html" rel="external">
          "Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/7020.html" rel="external">
          "Epidemiology, pathogenesis, microbiology, and diagnosis of hospital-acquired and ventilator-associated pneumonia in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2699.html" rel="external">
          "
          <i>
           Clostridioides difficile
          </i>
          infection in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4100424287">
         <span class="h2">
          Initial management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with suspected infection are ideally given empiric antibiotic therapy after blood samples have been obtained for culture. In general, the empiric regimens for post-ERCP intra-abdominal infections include antimicrobial activity against biliary flora, and this is discussed separately  (
         <a class="graphic graphic_table graphicRef106950" href="/z/d/graphic/106950.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/658.html" rel="external">
          "Acute cholangitis: Clinical manifestations, diagnosis, and management", section on 'Antibiotics'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101694.html" rel="external">
          "Antimicrobial approach to intra-abdominal infections in adults"
         </a>
         .)
        </p>
        <p>
         The duration of antibiotic therapy is individualized and is informed by blood culture results, imaging results, and source of infection. For patients in whom symptoms resolve but an infectious source is not identified, we typically discontinue antibiotics after three to five days. For patients with positive blood cultures and/or with a slower response to antibiotic therapy (ie, symptomatic improvement after five days of antibiotic therapy), we continue antibiotics for a total of 7 to 14 days.
        </p>
        <p>
         For patients in whom a diagnosis of intra-abdominal infection is established, further management is discussed below. (See
         <a class="local">
          'Specific post-ERCP infections'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H412592666">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of an ERCP-related infection includes other etiologies of post-ERCP fever and abdominal pain:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Post-ERCP perforation – Duodenal perforation related to ERCP may be recognized during the procedure based on fluoroscopic imaging, or the patient may present hours after the procedure with abdominal pain, fever, and leukocytosis. Thus, the diagnosis of duodenal perforation may be established during ERCP and/or with computed tomography scan. (See
         <a class="medical medical_review" href="/z/d/html/634.html" rel="external">
          "Post-ERCP perforation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute post-ERCP pancreatitis – The diagnosis of post-ERCP pancreatitis is established in patients with abdominal pain who have elevated amylase and/or lipase by &gt;3 times the upper limit of normal at more than 24 hours after ERCP and who require hospital admission or prolongation of a planned postprocedure admission [
         <a href="#rid19">
          19-21
         </a>
         ]. Fever may be present but is typically uncommon in patients with acute pancreatitis. The diagnosis and management of post-ERCP pancreatitis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/629.html" rel="external">
          "Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2593108497">
         <span class="h1">
          SPECIFIC POST-ERCP INFECTIONS
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Acute cholangitis
         </span>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Incidence and risk factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholangitis is one of the most common infectious events related to ERCP with a reported incidence that ranges from 1 to 3 percent [
         <a href="#rid2">
          2,5,22
         </a>
         ].
        </p>
        <p>
         Risk factors for post-ERCP cholangitis include [
         <a href="#rid15">
          15
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Incomplete biliary drainage – Patients with an obstructed biliary system for whom biliary drainage is not established are at risk for cholangitis. Such patients include those with the following conditions:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Malignant biliary obstruction and/or stent occlusion – For patients with a biliary malignancy, hilar obstruction is a risk factor for incomplete biliary drainage. In addition, biliary stents may become occluded due to tumor ingrowth and/or overgrowth, retained stones or sludge, or bacterial biofilm [
         <a href="#rid23">
          23
         </a>
         ]. The evaluation and management of patients with suspected stent occlusion is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">
          "Endoscopic stenting for malignant biliary obstruction"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Incomplete stone clearance (eg, retained stone fragments following mechanical lithotripsy). (See
         <a class="medical medical_review" href="/z/d/html/674.html" rel="external">
          "Endoscopic management of bile duct stones", section on 'Mechanical lithotripsy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of primary sclerosing cholangitis – Patients with primary sclerosing cholangitis who undergo ERCP are at increased risk for developing cholangitis, and this is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/661.html" rel="external">
          "Primary sclerosing cholangitis in adults: Management", section on 'Endoscopic therapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cholangioscopy – Miniature endoscopes and catheters have been developed for direct visualization of the bile duct, and this examination is referred to as cholangioscopy. Such instrumentation of the bile duct has been associated with risk of bacteremia and subsequent cholangitis [
         <a href="#rid24">
          24,25
         </a>
         ]. In an observational study of 57 patients who underwent ERCP with cholangioscopy, five patients had post-procedure bacteremia (9 percent), and four patients developed cholangitis requiring hospital admission (7 percent) [
         <a href="#rid25">
          25
         </a>
         ]. Biopsy sampling during cholangioscopy was associated with higher rates of bacteremia compared with no biopsy sampling (29 versus 5 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of liver transplantation – Liver transplant recipients are at increased risk for infection because of immunosuppression and because of increased likelihood for incomplete biliary drainage. These issues are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4596.html" rel="external">
          "Liver transplantation in adults: Endoscopic management of biliary adverse events"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other factors – Other risk factors include delay in performing ERCP (ie, &gt;48 hours after presentation) [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Clinical features and diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Cholangitis typically develops within 72 hours after ERCP, and the most common symptoms are fever with chills, right upper quadrant pain, and jaundice (Charcot's triad) [
         <a href="#rid15">
          15
         </a>
         ]. Mental status changes and hypotension may occur in patients with suppurative (severe) cholangitis (Reynold's pentad), whereas hypotension may be the only presenting symptom in older patients. Patients with acute cholangitis can also present with complications related to bacteremia, including liver abscess, sepsis, and multiple organ system dysfunction [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Patients with suspected post-ERCP cholangitis are diagnosed in the same manner as patients with acute cholangitis due to other causes (ie, temperature &gt;38⁰C combined with cholestasis as demonstrated by elevated liver tests and imaging). (See
         <a class="medical medical_review" href="/z/d/html/658.html" rel="external">
          "Acute cholangitis: Clinical manifestations, diagnosis, and management"
         </a>
         .)
        </p>
        <p>
         Cultures should also be obtained from bile that is aspirated during repeat ERCP because bile cultures have been associated with higher diagnostic yield than blood cultures [
         <a href="#rid28">
          28,29
         </a>
         ]. In a study including 93 patients with acute cholangitis who underwent ERCP, bile culture was associated with higher rates of a positive culture result compared with blood culture (97 versus 32 percent) [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         Post-ERCP cholangitis can be graded as mild, moderate, or severe based upon a consensus definition [
         <a href="#rid19">
          19,30
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mild – Temperature &gt;38⁰C for 24 to 48 hours
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Moderate – Febrile or septic illness requiring more than three days of hospital treatment or endoscopic or percutaneous intervention
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe – Septic shock or requiring procedural intervention
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cornerstone of treatment for cholangitis is decompression of the obstructed biliary ducts and supportive care with antibiotic therapy. For patients with biliary obstruction related to an occluded biliary stent, an ERCP-guided stent exchange is typically performed  (
         <a class="graphic graphic_picture graphicRef134726" href="/z/d/graphic/134726.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef134727" href="/z/d/graphic/134727.html" rel="external">
          picture 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">
          "Endoscopic stenting for malignant biliary obstruction", section on 'Stent occlusion'
         </a>
         .)
        </p>
        <p>
         The management of acute cholangitis is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/658.html" rel="external">
          "Acute cholangitis: Clinical manifestations, diagnosis, and management", section on 'Management'
         </a>
         .).
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Acute cholecystitis
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with an intact gallbladder who develop common bile duct stones, most centers perform cholecystectomy after ERCP with biliary sphincterotomy and stone removal. (See
         <a class="medical medical_review" href="/z/d/html/674.html" rel="external">
          "Endoscopic management of bile duct stones"
         </a>
         .)
        </p>
        <p>
         Timing of cholecystectomy in patients who are treated for choledocholithiasis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13922.html" rel="external">
          "Choledocholithiasis: Clinical manifestations, diagnosis, and management", section on 'Subsequent evaluation and management'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h3">
          Incidence and pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The incidence of post-ERCP acute cholecystitis has ranged from less than 0.5 to nearly 9 percent in various reports; however, most large series report an incidence of ≤0.5 percent [
         <a href="#rid20">
          20,31-33
         </a>
         ]. The pathogenesis may be related to the introduction of nonsterile contrast material into a poorly emptying gallbladder and/or obstruction of the cystic duct from malignancy, gallstone, or a biliary stent [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         For patients with an intact gallbladder, cholecystitis may occur if a self-expandable metal stent (SEMS) is placed across the origin of the cystic duct, resulting in a functional gallbladder obstruction [
         <a href="#rid34">
          34,35
         </a>
         ]. The risk of acute cholecystitis related to SEMS placement is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13925.html" rel="external">
          "Endoscopic stenting for malignant biliary obstruction", section on 'Cholecystitis'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h3">
          Clinical features and diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Acute cholecystitis following ERCP should be suspected in patients who present with fever, abdominal pain, abdominal tenderness localized in the right upper quadrant, and leukocytosis. The diagnosis is confirmed with imaging (typically, ultrasonography or computed tomography) that shows thickening of the gallbladder wall and pericholecystic fluid. (See
         <a class="medical medical_review" href="/z/d/html/666.html" rel="external">
          "Acute calculous cholecystitis: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Management
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of acute cholecystitis following ERCP is the same as the management for acute cholecystitis from other causes and generally includes antibiotic therapy and cholecystectomy (or nonsurgical gallbladder drainage). The management of acute cholecystitis is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3684.html" rel="external">
          "Treatment of acute calculous cholecystitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Other infections
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other post-ERCP abdominal infections that have been reported include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bacterial peritonitis
         <strong>
         </strong>
         –
         <strong>
         </strong>
         For patients with cirrhosis complicated by ascites, bacterial peritonitis has been associated with ERCP. In a cohort study including 1930 patients with cirrhosis who underwent ERCP and a control group of patients with cirrhosis who underwent non-pancreaticobiliary endoscopy, ERCP was associated with higher rates of postprocedure bacterial peritonitis compared with other endoscopic procedures (2.2 versus 1.1 percent) [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acute pancreatic ductitis – Acute pancreatic ductitis associated with pancreatic duct obstruction has been rarely reported following ERCP [
         <a href="#rid37">
          37,38
         </a>
         ]. As an example, acute suppurative pancreatic ductitis occurred after ERCP in a patient with cancer of the pancreatic head, and successful pancreatic drainage was achieved with pancreatic stent placement [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1049340549">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118263.html" rel="external">
          "Society guideline links: Endoscopic retrograde cholangiopancreatography (ERCP)"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/116414.html" rel="external">
          "Society guideline links: Biliary infection and obstruction"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H325742969">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2006.html" rel="external">
          "Patient education: ERCP (endoscopic retrograde cholangiopancreatography) (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General principles
         </strong>
         – Biliary drainage, usually by endoscopic retrograde cholangiopancreatography (ERCP), is essential for treating patients with acute obstructive cholangitis. However, cholangitis is the most common infectious adverse event associated with ERCP. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Patients with biliary obstruction and/or impaired host defenses are more susceptible to developing infection. Bacteremia may result from translocation of endogenous bacteria into the blood stream via mucosal trauma. In addition, injection of contrast material during ERCP may also result in bacteria being introduced into a previously sterile space. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preventive strategies
         </strong>
         – Strategies to reduce the risk of post-ERCP infection include (see
         <a class="local">
          'Preventive strategies'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Antibiotic prophylaxis – Antibiotic prophylaxis is recommended in selected patients undergoing ERCP who are at higher risk for infection  (
         <a class="graphic graphic_table graphicRef54121" href="/z/d/graphic/54121.html" rel="external">
          table 1
         </a>
         ). Specific antibiotic regimens are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2545.html" rel="external">
          "Antibiotic prophylaxis for gastrointestinal endoscopic procedures", section on 'Endoscopic retrograde cholangiopancreatography (ERCP)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         General endoscopic techniques – ERCP-related techniques include aspirating bile before injecting contrast material and using the minimum volume of contrast that is needed to obtain diagnostic fluoroscopic images.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Establishing biliary drainage – For patients with biliary obstruction, the goal of endoscopic intervention is to establish complete, long-term biliary drainage during the initial endoscopic session.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Adhering to protocols for endoscope reprocessing – Protocols for endoscope disinfection and reprocessing are informed by regulatory agencies, manufacturers, and professional societies, and these issues are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">
          "Preventing infection transmitted by gastrointestinal endoscopy"
         </a>
         .).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Approach to the patient with suspected infection
         </strong>
         – ERCP-related infection should be suspected in patients who develop fever (frequently with chills) and/or abdominal pain within 72 hours after ERCP. Initial evaluation and management includes laboratory testing, diagnostic imaging to exclude biliary obstruction and cholecystitis, and empiric antibiotic therapy  (
         <a class="graphic graphic_table graphicRef106950" href="/z/d/graphic/106950.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Approach to the patient with suspected infection'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/101694.html" rel="external">
          "Antimicrobial approach to intra-abdominal infections in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Specific infectious adverse events
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute cholangitis
         </strong>
         – Signs and symptoms of cholangitis include fever, right upper quadrant pain, and jaundice. Mental status changes and hypotension can occur in patients with suppurative (severe) cholangitis, whereas hypotension may be the only presenting symptom in older patients. (See
         <a class="local">
          'Acute cholangitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         The cornerstone of treatment for cholangitis is decompression of the obstructed biliary ducts and supportive care with antibiotic therapy. (See
         <a class="medical medical_review" href="/z/d/html/658.html" rel="external">
          "Acute cholangitis: Clinical manifestations, diagnosis, and management", section on 'Management'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acute cholecystitis
         </strong>
         – The diagnosis of acute cholecystitis following ERCP should be suspected in patients who develop tenderness localized in the right upper quadrant and have thickening of the gallbladder wall and pericholecystic fluid seen on ultrasound or computed tomography. (See
         <a class="local">
          'Acute cholecystitis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Management of acute cholecystitis following ERCP is the same as the management for acute cholecystitis from other causes and generally includes antibiotic therapy and cholecystectomy (or nonsurgical gallbladder drainage). (See
         <a class="medical medical_review" href="/z/d/html/3684.html" rel="external">
          "Treatment of acute calculous cholecystitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H868257182">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Francesco Ferrara, MD, and Silvano Loperfido, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Anderson DJ, Shimpi RA, McDonald JR, et al. Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia. Am J Infect Control 2008; 36:592.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007; 102:1781.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy 2007; 39:793.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang P, Li ZS, Liu F, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol 2009; 104:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapral C, Mühlberger A, Wewalka F, et al. Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation. Eur J Gastroenterol Hepatol 2012; 24:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ASGE Standards of Practice Committee, Khashab MA, Chithadi KV, et al. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc 2015; 81:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson DB. Infectious disease complications of GI endoscopy: Part I, endogenous infections. Gastrointest Endosc 2003; 57:546.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subhani JM, Kibbler C, Dooley JS. Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP). Aliment Pharmacol Ther 1999; 13:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zong Z. Biliary tract infection or colonization with Elizabethkingia meningoseptica after endoscopic procedures involving the biliary tract. Intern Med 2015; 54:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szary NM, Al-Kawas FH. Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them. Gastroenterol Hepatol (N Y) 2013; 9:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen M, Wang L, Wang Y, et al. Risk factor analysis of post-ERCP cholangitis: A single-center experience. Hepatobiliary Pancreat Dis Int 2018; 17:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Epstein L, Hunter JC, Arwady MA, et al. New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014; 312:1447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Romney Humphries, Shuan Yang, Stephen Kim. Duodenoscope-Related Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced Molecular Diagnostics. Clin Infect Dis 2017; 65:1159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Centers for Disease Control and Prevention (CDC). Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013. MMWR Morb Mortal Wkly Rep 2014; 62:1051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ASGE Standards of Practice Committee, Chandrasekhara V, Khashab MA, et al. Adverse events associated with ERCP. Gastrointest Endosc 2017; 85:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ishiwatari H, Satoh T, Sato J, et al. Bile aspiration during EUS-guided hepaticogastrostomy is associated with lower risk of postprocedural adverse events: a retrospective single-center study. Surg Endosc 2021; 35:6836.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bang JY, Hawes R, Varadarajulu S. Equivalent performance of single-use and reusable duodenoscopes in a randomised trial. Gut 2021; 70:838.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tonolini M, Pagani A, Bianco R. Cross-sectional imaging of common and unusual complications after endoscopic retrograde cholangiopancreatography. Insights Imaging 2015; 6:323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2020; 52:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kager LM, Sjouke B, van den Brand M, et al. The role of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography; a retrospective single-center evaluation. Scand J Gastroenterol 2012; 47:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawas T, Al Halabi S, Parsi MA, Vargo JJ. Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis. Gastrointest Endosc 2015; 82:256.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thosani N, Zubarik RS, Kochar R, et al. Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP. Endoscopy 2016; 48:424.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Othman MO, Guerrero R, Elhanafi S, et al. A prospective study of the risk of bacteremia in directed cholangioscopic examination of the common bile duct. Gastrointest Endosc 2016; 83:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Navaneethan U, Gutierrez NG, Jegadeesan R, et al. Delay in performing ERCP and adverse events increase the 30-day readmission risk in patients with acute cholangitis. Gastrointest Endosc 2013; 78:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katsinelos P, Dimiropoulos S, Katsiba D, et al. Pseudomonas aeruginosa liver abscesses after diagnostic endoscopic retrograde cholangiography in two patients with sphincter of Oddi dysfunction type 2. Surg Endosc 2002; 16:1638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chandra S, Klair JS, Soota K, et al. Endoscopic Retrograde Cholangio-Pancreatography-Obtained Bile Culture Can Guide Antibiotic Therapy in Acute Cholangitis. Dig Dis 2019; 37:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Negm AA, Schott A, Vonberg RP, et al. Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. Gastrointest Endosc 2010; 72:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci 2018; 25:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson DB. Infectious disease complications of GI endoscopy: part II, exogenous infections. Gastrointest Endosc 2003; 57:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Suk KT, Kim HS, Kim JW, et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc 2006; 64:522.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jang S, Stevens T, Parsi M, et al. Association of covered metallic stents with cholecystitis and stent migration in malignant biliary stricture. Gastrointest Endosc 2018; 87:1061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inamdar S, Berzin TM, Berkowitz J, et al. Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography. Liver Int 2016; 36:1457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujinaga T, Nishida T, Miyazaki M, et al. Acute suppurative pancreatic ductitis associated with pancreatic duct obstruction. Endoscopy 2013; 45 Suppl 2 UCTN:E135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang Z, Zhang PP, Bai Y, Wang D. A rare case of acute obstructive suppurative pancreatic ductitis associated with ERCP. Rev Esp Enferm Dig 2019; 111:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Isono Y, Matsusaki S, Tanaka H, et al. [Acute obstructive suppurative pancreatic ductitis after endoscopic retrograde cholangiopancreatography in a patient with carcinoma of the pancreatic head:a case report]. Nihon Shokakibyo Gakkai Zasshi 2016; 113:289.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 641 Version 32.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18926314" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Infectious complications following endoscopic retrograde cholangiopancreatography: an automated surveillance system for detecting postprocedure bacteremia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17509029" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Incidence rates of post-ERCP complications: a systematic survey of prospective studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17703388" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19098846" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Risk factors for ERCP-related complications: a prospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23114747" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Quality assessment of endoscopic retrograde cholangiopancreatography: results of a running nationwide Austrian benchmarking project after 5 years of implementation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25442089" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Antibiotic prophylaxis for GI endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12665767" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Infectious disease complications of GI endoscopy: Part I, endogenous infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10102939" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Review article: antibiotic prophylaxis for endoscopic retrograde cholangiopancreatography (ERCP).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25742887" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Biliary tract infection or colonization with Elizabethkingia meningoseptica after endoscopic procedures involving the biliary tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24719597" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29428105" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Risk factor analysis of post-ERCP cholangitis: A single-center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25291580" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : New Delhi metallo-β-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Duodenoscope-Related Outbreak of a Carbapenem-Resistant Klebsiella pneumoniae Identified Using Advanced Molecular Diagnostics
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24381080" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Notes from the Field: New Delhi metallo-β-lactamase-producing Escherichia coli associated with endoscopic retrograde cholangiopancreatography - Illinois, 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27546389" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Adverse events associated with ERCP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33398558" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Bile aspiration during EUS-guided hepaticogastrostomy is associated with lower risk of postprocedural adverse events: a retrospective single-center study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32895332" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Equivalent performance of single-use and reusable duodenoscopes in a randomised trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25716101" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cross-sectional imaging of common and unusual complications after endoscopic retrograde cholangiopancreatography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2070995" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Endoscopic sphincterotomy complications and their management: an attempt at consensus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8782497" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Complications of endoscopic biliary sphincterotomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31863440" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22242617" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The role of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography; a retrospective single-center evaluation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25982849" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Self-expandable metal stents versus plastic stents for malignant biliary obstruction: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26919263" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26116469" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : A prospective study of the risk of bacteremia in directed cholangioscopic examination of the common bile duct.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23528654" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Delay in performing ERCP and adverse events increase the 30-day readmission risk in patients with acute cholangitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12085136" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Pseudomonas aeruginosa liver abscesses after diagnostic endoscopic retrograde cholangiography in two patients with sphincter of Oddi dysfunction type 2.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30282078" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Endoscopic Retrograde Cholangio-Pancreatography-Obtained Bile Culture Can Guide Antibiotic Therapy in Acute Cholangitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20541201" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29032610" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12709700" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Infectious disease complications of GI endoscopy: part II, exogenous infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9684657" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11232684" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Complications of diagnostic and therapeutic ERCP: a prospective multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16996343" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28867074" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Association of covered metallic stents with cholecystitis and stent migration in malignant biliary stricture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26913829" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Decompensated cirrhosis may be a risk factor for adverse events in endoscopic retrograde cholangiopancreatography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23716098" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Acute suppurative pancreatic ductitis associated with pancreatic duct obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30284907" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A rare case of acute obstructive suppurative pancreatic ductitis associated with ERCP.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26853989" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : [Acute obstructive suppurative pancreatic ductitis after endoscopic retrograde cholangiopancreatography in a patient with carcinoma of the pancreatic head:a case report].
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
